Selinisol tablets have serious side effects, must the drug be discontinued?

Selinexor (Selinexor) is a prescription drug that plays an important role in the treatment of multiple myeloma and some diffuse large B-cell lymphomas. Selinisol is often used as an alternative treatment option when other drugs are ineffective or ineffective. However, like many medications, it can cause a range of side effects. The severity of these side effects varies from person to person and may sometimes require discontinuation of the drug, but sometimes it can be effectively controlled by adjusting the dose or taking appropriate measures.

When selinesol is used in combination with bortezomib and dexamethasone, patients may experience side effects such as thrombocytopenia, nausea, fatigue, anemia, decreased appetite, diarrhea, and peripheral neuropathy. Among these side effects, pneumonia, cataracts, sepsis, diarrhea, vomiting and anemia were listed as the most serious reactions.

On the other hand, when selinesol is given alone with dexamethasone, the most common side effects include nausea, vomiting, decreased appetite, weight loss, diarrhea, fatigue, thrombocytopenia, anemia, leukopenia, and hyponatremia. In these cases, pneumonia, sepsis, thrombocytopenia, anemia, and kidney damage are considered the most serious potential risks.

Faced with these possible side effects, patients and doctors need to closely monitor the body's response and decide whether to discontinue medication on a case-by-case basis. In some cases, side effects may be managed effectively without stopping the drug by adjusting the drug dose or taking appropriate supportive care measures. However, discontinuation may be necessary when side effects are severe enough to affect the patient's quality of life or physical health. Therefore, individual variability and close monitoring are key with selinesol use.